Two Doses, One Failed Execution: The Unanswered Questions Surrounding Christa Pike’s Case

Two doses of lethal drugs. One failed execution. And a growing list of unanswered questions.

What happened inside Tennessee’s execution chamber on September 30, 2026, has now become the focus of a major investigation.

Christa Pike, 50, was scheduled to die by lethal injection at Riverbend Maximum Security Insтιтution for the 1995 murder of 19-year-old Colleen Slemmer.

But the execution did not go as planned.

Officials administered two doses of pentobarbital, yet Pike remained alive.

Witnesses reported that she continued breathing long after the injections. The procedure eventually ended, and Pike was transported to a hospital for emergency medical treatment.

The Tennessee Department of Correction maintained that its established execution protocol had been followed.

However, the state’s protocol provided no further instructions if a prisoner survived the second dose.

Now, new developments are raising even more questions.

On October 6, Pike’s attorneys confirmed that she had regained consciousness and was speaking after spending days on a ventilator.

Her recovery remains uncertain.

On October 7, a Tennessee judge ordered officials to preserve evidence from the execution attempt, including records and materials that could help establish what happened.

Meanwhile, Gov. Bill Lee has suspended further executions and ordered an independent investigation. Tennessee’s corrections commissioner has also resigned.

The biggest unanswered question remains: Why did the lethal injection procedure fail?

My take: The most troubling issue is not simply that two doses failed to cause Pike’s death. It is that Tennessee carried out its execution procedure without a clearly established explanation for what went wrong. Until investigators examine the evidence and release their findings, questions about the state’s execution system will remain. Colleen Slemmer’s family also deserves clear answers after more than three decades of waiting.